Veracyte up on 2022 sales forecast raise
** Veracyte Inc's shares VCYT.O rise 24.9% to $24.35
-biggest one-day pct. gain in about 3 years
** Co late on Wednesday raised 2022 sales forecast to $288
million to $293 million, compared with $272 million to $280
million urn:newsml:reuters.com:*:nBw61lkd8a
** Diagnostic firm's sales grew 25% to $75.6 million in the
third quarter
** Including session gains, stock down ~41% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina